Alan Irvine, MD, DSc: Atopic Dermatitis and the Biological Clock
Alan Irvine, MD, DSc, discusses his Revolutionizing Atopic Dermatitis session and exciting advances in AD.
Upadacitinib for Vitiligo Improves Patient Health-Related QoL After 24 Weeks
The promising data on upadacitinib was presented at the 2023 Revolutionizing Vitiligo Virtual Conference
Derm In The News: December 3-9
Keep up with the latest headlines in dermatology from the past week, including efficacy of nemolizumab in prurigo nodularis, the addition of a skin bank in northern India where skin banks are scarce, and more.
The Weekly Roundup: December 4-8
ICYMI, this week we had articles about upcoming conferences in 2024, the potential causal relationship between pure hypercholesterolemia and psoriasis, the first patient dosed in Kymera's phase 2 AD trial, and more.
Journal Digest: December 8
This week’s collection of the latest dermatologic studies covers the burden of pediatric AD, skin cancer risk associated with combined methotrexate and NB-UVB therapy in patients with moderate to severe PsO, stigma towards patients with acne, and detection of nonmelanoma skin cancers in Mohs surgical sections using deep learning.
Holiday Merriment and Sharing the Microbiome
The holidays are a wonderful time to catch up with family members on where the journey of life has taken us during the past year, but they are also a time to share microbiome organisms with others who are genetically similar to us.
Celebrating 2023’s Achievements in Dermatology
As 2023 ends and 2024 approaches, we are thankful for a year dedicated to new therapeutics for patients in need, and we look forward to a new year of continued innovations.
94% of Patients With Atopic Dermatitis Report Satisfaction With Baricitinib Treatment
Approximately 76% of patients reported being "satisfied," while 18% reported they were "very satisfied" with treatment.
High Levels of Cholesterol, Low-Density Lipoprotein Cholesterol, Among Genetic Risk Factors for Psoriasis
Investigators explored the genetic relationship between psoriatic disease and serum lipid levels.
Dermavant Shares Positive Phase 4 Data for Tapinarof 1% in Adults With Plaque Psoriasis of the Head and Neck
Approximately 96.2% of patients had achieved PASI75 by week 12 of the study.
First Patient Dosed in Kymera’s Phase 2 AD Trial of KT-474
KT-474 is a first-in-class, investigational IRAK4 degrader.
Managing Atopic Dermatitis Postpartum and While Breastfeeding
A patient returns to your clinic seeking systemic therapy for her AD while postpartum and breastfeeding. Test your knowledge on injectables.
Pointers With Portela: Pre-Teen Skin Care Routine
In this week’s Pointers With Portela, the 208SkinDoc gives his recommendations for a pre-teen skin care routine.
Katie Martin, PA-C, Share Insights Into Aesthetic Innovations in 2023 and What’s to Come in 2024
The approval of Galderma’s Restylane Eyelight was one of Martin’s top highlights of 2023.
The Importance of Understanding Inflammatory Markers
A 12-year-old patient and their family seeks answers to adjust lifestyle habits and therapies. Test your knowledge on what cytokines can indicate.
Can Topical Retinoids Decrease Atrophic Scars?
Linda Stein Gold, MD, reviewed recent studies of various topical retinoids and their ability to decrease atrophic scars during the 2023 ARM Yourself With Knowledge webinar.
Pure Hypercholesterolemia and Psoriasis Share a Causal Link, Study Says
Researchers explored the potential causal relationship between pure hypercholesterolemia, a recognized risk factor for cardiovascular disease, and psoriasis.
Vitiligo Case Report: A 9-Year Old Patient With White Macules, Halo Nevus
Jordan Bui and Bernard A. Cohen, MD, review a case of a young patient with vitiligo.
Out of Pocket Costs for Alopecia Treatment Associated With Significant Economic Burden
The study found that alopecia has a significant economic burden on women and their families.
The Cutaneous Connection: Splish, Splash, AD Management Starts in the Bath
Leading atopic dermatitis experts weigh in on bath routines with different ages, cultures, and more to consult patients and their families.
Patient Does Not Want to Pass AD to Her Unborn Child: Is It Possible?
A woman is trying to conceive and wants to take all steps to prevent her child from inheriting severe atopic dermatitis. Test your knowledge on recommendations.
Hilary Baldwin, MD, Discusses Impacts of Isotretinoin Use
Baldwin reviewed inflammatory bowel disease, depression, and pregnancy during the 2023 ARM Yourself With Knowledge webinar.
Almirall, Barcelona Supercomputing Center, Nostrum Biodiscovery to Partner in New AI Research
The collaboration, named ARTIBAND, will extend over a 3-year period
DecisionDx-Melanoma Survey Reveals Patient Care Insights Among NPs and PAs
DecisionDx-Melanoma significantly influences treatment plans for melanoma patients, as reported by 82.4% of surveyed nurse practitioners and physician assistants.
Lipid Imaging Mass Spectrometry Aids in Accurate Skin Cancer Diagnosis, Study Says
Investigators used LIMS to classify melanoma samples as tumors and non-tumors.
POLL: Have You Considered Debulking Before PDT to Treat Pigmented BCCs?
Click here to answer this week's skin cancer poll.
Addressing Quality of Life Specifics Associated With Atopic Dermatitis and Skin of Color
Zakiya Pressley Rice, MD, took a deep dive into how atopic dermatitis severity and increased rates of grade school absenteeism affect patients with skin of color during a recent Masterclasses in Dermatology meeting.
Exploring the Relationship Between AD, Psychological Stress, Sleep Disturbances, and Salivary Biomarkers
Understanding these relationships is crucial for developing effective clinical management strategies for patients with AD, according to a recent literature review.
Renata Block, PA-C, Reflects on Dermatology Innovations in 2023
2023 was full of advancements in both medical and cosmetic dermatology, and 2024 is shaping up to be just as exciting.
What Conferences Are You Planning to Attend in Quarter 1 of 2024?
Ahead of 2024, Dermatology Times wants to know what conferences and meetings you plan to attend in early 2024. Share your thoughts with us by December 10.
2 Clarke Drive Cranbury, NJ 08512